NEWS and OPINIONS

After groundbreaking CRISPR therapy, a homecoming

After groundbreaking CRISPR therapy, a homecoming

By Meghana Keshavan - Stat News - From my colleague Jason Mast: KJ Muldoon, the first infant treated with a personalized gene-editing drug, has been discharged from the hospital for the first time in his life, the Children’s Hospital of Philadelphia announced Tuesday....

read more
CAR T-Cell Therapy: New Advances Move On Past Setbacks

CAR T-Cell Therapy: New Advances Move On Past Setbacks

By Tiffany Yesavag - Genetic Bioengineering & Biotechnology News - Chimeric antigen receptor (CAR) T-cell therapy is an innovative cancer treatment that engineers a patient’s own T cells to target and destroy cancer cells. While the field has sparked significant...

read more
New Cell Therapy For Resistant Hodgkins Patients

New Cell Therapy For Resistant Hodgkins Patients

By Derek Lowe - Science - Here’s some more good news on the immuno-oncology front. Hodgkin lymphoma (HL) is one of those cancer types whose prognosis is in the “A lot better than it used to be, but. . .” category. There are several varieties (with the “classic” form...

read more